Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Sosei Heptares and Lilly Enter Multi-target Collaboration and License Agreement in Diabetes and Metabolic Diseases
Sosei Group Corporation announces it has entered a drug discovery collaboration with Eli Lilly and […]
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Telix and RefleXion Expand Partnership for Prostate Cancer Treatment
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RefleXion Medical, Inc. (Hayward, California, U.S.) (RefleXion) […]
Theolytics Starts a £1m Project in Collaboration With the University of Sheffield, Supported by Innovate UK to Develop a Novel Therapy for Multiple Myeloma Patients
Theolytics is a biotechnology company harnessing viruses to combat disease. The company has been awarded […]
TheraVet Optimizes its Commercial Strategy in France with a New Distribution Agreement with Elvetis
TheraVet, a pioneering biotechnology company in the treatment of bone and joint diseases in pets, […]
Kling Biotherapeutics Appoints Michael Koslowski, M.D. As Chief Executive Officer
Kling Biotherapeutics, a clinical-stage company pioneering the discovery and development of novel antibody-based therapeutics, today […]
SynAct Pharma to Make Strategic Acquisition of Swiss Biotech Company TXP Pharma
SynAct Pharma AB has announced that the company has entered into a conditional agreement on […]
HitGen Announces Research Agreement with Nitrase Therapeutics Focused on DNA-Encoded Library Based Drug Discovery
Shanghai Stock Exchange-listed company HitGen has announced that it has entered into a research agreement […]
Phanes Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate PT199 in Combination with Tislelizumab
Phanes Therapeutics, a clinical-stage biotech company focused on innovative drug discovery and development in oncology, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more